Alexandria to sell Newton office complex once destined to be labs


The life sciences developer bought the property for $235 million in early 2020, but this week announced a $139 million impairment charge.

Previous Rubenstein Partners finds success in 'desire for flexibility' at Chesterbrook
Next Fiserv reports first-quarter growth despite banking industry turmoil